Medicare advantage

Medicare advantage has been studied in 5 papers since 2023: 5 observational studies in people. The newest paper, Dec 31, 2024: “FUNCTIONAL OUTCOME IN HOME HEALTH AMONG TRADITIONAL MEDICARE AND MEDICARE ADVANTAGE BENEFICIARIES WITH DEMENTIA”.

Intervention

5 papers study it8 findingsUpdated

See all 5 papers on medicare advantage

At a glance

The findings reach people, from one lab or study. 3 independent labs in 1 country.

“MA enrollees were 26% less likely to report improvement or maintenance of ADL composite score (95% CI: 0.71-0.77) than TM.”
FUNCTIONAL OUTCOME IN HOME HEALTH AMONG TRADITIONAL MEDICARE AND MEDICARE ADVANTAGE BENEFICIARIES WITH DEMENTIAGSA 2024 abstract2024doi:10.1093/geroni/igae098.3572

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 3 independent labs in 1 country
  • Funders: National Institute on Aging and 2 more
  • Humans5

What did studies of medicare advantage find?

7

Studies of medicare advantage measured 7 outcomes, among them Home health visits, ADL composite score improvement or maintenance and gait speed.

Home health visits

no changein humans1

1 study
  1. Medicare advantage was not clearly linked with home health visits in humans during home health admission (2.14 vs. 2.13 visits, P=0.39).

    “There was no difference in the number of HH visits between TM and MA enrollees (2.14 vs. 2.13; P=0.39).”

    Humansduring home health admission

    FUNCTIONAL OUTCOME IN HOME HEALTH AMONG TRADITIONAL MEDICARE AND MEDICARE ADVANTAGE BENEFICIARIES WITH DEMENTIA

    GSA 2024 abstract

ADL composite score improvement or maintenance

downin humans1

1 study
  1. Medicare advantage is linked with lower ADL composite score improvement or maintenance in humans during home health admission.

    “MA enrollees were 26% less likely to report improvement or maintenance of ADL composite score (95% CI: 0.71-0.77) than TM.”

    Humansduring home health admission

    FUNCTIONAL OUTCOME IN HOME HEALTH AMONG TRADITIONAL MEDICARE AND MEDICARE ADVANTAGE BENEFICIARIES WITH DEMENTIA

    GSA 2024 abstract

Gait speed

no changein humans1

1 study
  1. Medicare advantage was not clearly linked with gait speed in humans (adjusted mean difference, -0.010 m/s [95% CI, -0.067 to 0.049 m/s]).

    “there were no differences between MA and TM enrollees in the 1-year change in FI score (mean [SD], 0.016 [0.071] vs 0.014 [0.066]; adjusted mean difference, 0.001 [95% CI, -0.004 to 0.005]), FFP score (mean [SD], 0.017 [1.004] vs 0.007 [0.958]; adjusted mean difference, -0.009 [95% CI, -0.067 to 0.049]), SPPB score (mean [SD], -0.144 [2.064] vs -0.211 [1.968]; adjusted mean difference, 0.068 [95% CI, -0.076 to 0.212]), and gait speed”

    Humans1 yearn = 7,063

    Frailty in Medicare Advantage Beneficiaries and Traditional Medicare Beneficiaries

    JAMA network open

More on Gait speed

Short Physical Performance Battery

no changein humans1

1 study
  1. Medicare advantage was not clearly linked with Short Physical Performance Battery in humans (adjusted mean difference, 0.068 [95% CI, -0.076 to 0.212]).

    “there were no differences between MA and TM enrollees in the 1-year change in FI score (mean [SD], 0.016 [0.071] vs 0.014 [0.066]; adjusted mean difference, 0.001 [95% CI, -0.004 to 0.005]), FFP score (mean [SD], 0.017 [1.004] vs 0.007 [0.958]; adjusted mean difference, -0.009 [95% CI, -0.067 to 0.049]), SPPB score”

    Humans1 yearn = 7,063

    Frailty in Medicare Advantage Beneficiaries and Traditional Medicare Beneficiaries

    JAMA network open

More on Short Physical Performance Battery

Fried frailty phenotype

no changein humans1

1 study
  1. Medicare advantage was not clearly linked with Fried frailty phenotype in humans (adjusted mean difference, -0.009 [95% CI, -0.067 to 0.049]).

    “there were no differences between MA and TM enrollees in the 1-year change in FI score (mean [SD], 0.016 [0.071] vs 0.014 [0.066]; adjusted mean difference, 0.001 [95% CI, -0.004 to 0.005]), FFP score”

    Humans1 yearn = 7,063

    Frailty in Medicare Advantage Beneficiaries and Traditional Medicare Beneficiaries

    JAMA network open

More on Fried frailty phenotype

Frailty index

no changein humans1

1 study
  1. Medicare advantage was not clearly linked with frailty index in humans (adjusted mean difference, 0.001 [95% CI, -0.004 to 0.005]).

    “One year later, there were no differences between MA and TM enrollees in the 1-year change in FI score”

    Humans1 yearn = 7,063

    Frailty in Medicare Advantage Beneficiaries and Traditional Medicare Beneficiaries

    JAMA network open

More on Frailty index

Physical function

no changein humans1

1 study
  1. Medicare advantage was not clearly linked with physical function in humans (beneficiaries reporting rehabilitation) (-0.46 vs -0.21, p=0.069).

    “MA beneficiaries had a similar decline in SPPB (-0.46 [SD 1.8] vs. -0.21 [SD 2.7], p-value 0.069) and adapted FIM (-1.05 [SD 3.7] vs. -1.13 [SD 5.45], p-value 0.764) compared to FFS.”

    Humansbeneficiaries reporting rehabilitation

    Long-term outcomes after rehabilitation in Medicare Advantage and fee-for-service beneficiaries

    Journal of the American Geriatrics Society

What is medicare advantage linked with?

1

Studies link medicare advantage with functional outcome.

Functional outcome

downin humans1

1 study
  1. Medicare advantage is associated with functional outcome in humans with Alzheimer's disease and related dementias during home health admission.

    “MA enrollees were 26% less likely to report improvement or maintenance of ADL composite score (95% CI: 0.71-0.77) than TM.”

    Humanswith Alzheimer's disease and related dementias during home health admissionn = 81,735

    FUNCTIONAL OUTCOME IN HOME HEALTH AMONG TRADITIONAL MEDICARE AND MEDICARE ADVANTAGE BENEFICIARIES WITH DEMENTIA

    GSA 2024 abstract

Funding

1 grant since 2021

Agency for Healthcare Research and Quality$1.5M

Latest